Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Francisco J. Ortega-Nogales"'
Autor:
Beatriz Marcos-Ramiro, Ana Gil-Ordóñez, Nagore I. Marín-Ramos, Francisco J. Ortega-Nogales, Moisés Balabasquer, Pilar Gonzalo, Nora Khiar-Fernández, Loïc Rolas, Anna Barkaway, Sussan Nourshargh, Vicente Andrés, Mar Martín-Fontecha, María L. López-Rodríguez, Silvia Ortega-Gutiérrez
Publikováno v:
ACS Central Science, Vol 7, Iss 8, Pp 1300-1310 (2021)
Externí odkaz:
https://doaj.org/article/e4776e931dc0449ea27758d4421817c1
Autor:
Nora Khiar-Fernández, Silvia Ortega-Gutiérrez, Nagore I. Marín-Ramos, Pilar Gonzalo, Francisco J. Ortega-Nogales, María L. López-Rodríguez, Ana Gil-Ordóñez, Moisés Balabasquer, Loïc Rolas, Mar Martín-Fontecha, Anna Barkaway, Sussan Nourshargh, Beatriz Marcos-Ramiro, Vicente Andrés
Publikováno v:
ACS Central Science
ACS Central Science, Vol 7, Iss 8, Pp 1300-1310 (2021)
ACS Central Science, Vol 7, Iss 8, Pp 1300-1310 (2021)
Hutchinson–Gilford progeria syndrome (HGPS, progeria) is a rare genetic disease characterized by premature aging and death in childhood for which there were no approved drugs for its treatment until last November, when lonafarnib obtained long-soug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76de606dfeeead8a530b6a0380cd4a3f
https://hdl.handle.net/20.500.12105/15199
https://hdl.handle.net/20.500.12105/15199
Autor:
Nagore I. Marín-Ramos, Francisco J. Medrano, María L. López-Rodríguez, Moisés Balabasquer, Beatriz Marcos-Ramiro, Pedro Aguilar-Garrido, Silvia Ortega-Gutiérrez, Mark R. Philips, Miguel Gallardo, Ivan R. Torrecillas, Antonio A. Romero, Faustino Mollinedo, Ana Gil-Ordóñez, Ian Cushman, Francisco J. Ortega-Nogales, Mar Martín-Fontecha, Consuelo Gajate, Mercedes Campillo
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
12 p.-9 fig.-6 tab.-1 graph. abst.
Blockade of Ras activity by inhibiting its post-translational methylation catalyzed by isoprenylcysteine carboxylmethyltransferase (ICMT) has been suggested as a promising antitumor strategy. However, the pauci
Blockade of Ras activity by inhibiting its post-translational methylation catalyzed by isoprenylcysteine carboxylmethyltransferase (ICMT) has been suggested as a promising antitumor strategy. However, the pauci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fce8b0abff673ee34659d08d5012ba5a
https://doi.org/10.1021/acs.jmedchem.9b00145
https://doi.org/10.1021/acs.jmedchem.9b00145
Autor:
Ana Marquina, Jesús Jiménez-Barbero, Moisés Balabasquer, Sandra Blasco-Benito, Nagore I. Marín-Ramos, Silvia Ortega-Gutiérrez, Henar Vázquez-Villa, María L. López-Rodríguez, Ángeles Canales, Jaime Moscoso del Prado, Dulce Alonso, Mar Martín-Fontecha, Clara Andradas, Cristina Sánchez, Francisco J. Ortega-Nogales, Eduardo Pérez-Gómez
Publikováno v:
Journal of medicinal chemistry. 58(9)
Angiogenesis is a requirement for the sustained growth and proliferation of solid tumors, and the development of new compounds that induce a sustained inhibition of the proangiogenic signaling generated by tumor hypoxia still remains as an important
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b71de1ed03a7cedf7e0a65156638fb27
https://pubmed.ncbi.nlm.nih.gov/25906180
https://pubmed.ncbi.nlm.nih.gov/25906180